Your browser doesn't support javascript.
loading
Resolving therapy resistance mechanisms in multiple myeloma by multiomics subclone analysis.
Poos, Alexandra M; Prokoph, Nina; Przybilla, Moritz J; Mallm, Jan-Philipp; Steiger, Simon; Seufert, Isabelle; John, Lukas; Tirier, Stephan M; Bauer, Katharina; Baumann, Anja; Rohleder, Jennifer; Munawar, Umair; Rasche, Leo; Kortüm, K Martin; Giesen, Nicola; Reichert, Philipp; Huhn, Stefanie; Müller-Tidow, Carsten; Goldschmidt, Hartmut; Stegle, Oliver; Raab, Marc S; Rippe, Karsten; Weinhold, Niels.
Afiliação
  • Poos AM; Department of Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany.
  • Prokoph N; Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center, Heidelberg, Germany.
  • Przybilla MJ; Department of Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany.
  • Mallm JP; Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center, Heidelberg, Germany.
  • Steiger S; Division Computational Genomics and Systems Genetics, German Cancer Research Center, Heidelberg, Germany.
  • Seufert I; Genome Biology Unit, European Molecular Biology Laboratory, Heidelberg, Germany.
  • John L; Wellcome Sanger Institute, Wellcome Trust Genome Campus, Cambridge, United Kingdom.
  • Tirier SM; Single Cell Open Lab, German Cancer Research Center and BioQuant, Heidelberg, Germany.
  • Bauer K; Division of Chromatin Networks, German Cancer Research Center and BioQuant, Heidelberg, Germany.
  • Baumann A; Division of Chromatin Networks, German Cancer Research Center and BioQuant, Heidelberg, Germany.
  • Rohleder J; Department of Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany.
  • Munawar U; Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center, Heidelberg, Germany.
  • Rasche L; Division of Chromatin Networks, German Cancer Research Center and BioQuant, Heidelberg, Germany.
  • Kortüm KM; Single Cell Open Lab, German Cancer Research Center and BioQuant, Heidelberg, Germany.
  • Giesen N; Department of Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany.
  • Reichert P; Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center, Heidelberg, Germany.
  • Huhn S; Department of Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany.
  • Müller-Tidow C; Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center, Heidelberg, Germany.
  • Goldschmidt H; Department of Internal Medicine 2, University Hospital of Würzburg, Würzburg, Germany.
  • Stegle O; Department of Internal Medicine 2, University Hospital of Würzburg, Würzburg, Germany.
  • Raab MS; Mildred Scheel Early Career Center, University Hospital of Würzburg, Würzburg, Germany.
  • Rippe K; Department of Internal Medicine 2, University Hospital of Würzburg, Würzburg, Germany.
  • Weinhold N; Department of Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany.
Blood ; 142(19): 1633-1646, 2023 11 09.
Article em En | MEDLINE | ID: mdl-37390336
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Mieloma Múltiplo Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Mieloma Múltiplo Idioma: En Ano de publicação: 2023 Tipo de documento: Article